Phase 2
Completed N=70
Nonopioid Analgesia After Rotator Cuff Repair
Source: ClinicalTrials.gov NCT03818919 ↗Enrolled (actual)
70
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcomePrimary: Pain Levels — 2.4; 3 units on a scale
Summary
This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Levels |
2.4; 3 | — |
| PRIMARY Patient-Reported Outcomes Measurement Information System |
59.3; 60.0 | — |
Eligibility Criteria
Inclusion Criteria
- All adult patients over age 18 and scheduled for a primary or revision rotator cuff repair
Exclusion Criteria
- Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact rotator cuff
Data sourced from ClinicalTrials.gov (NCT03818919). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.